Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade: Supplemental File

Published: 14 June 2022| Version 1 | DOI: 10.17632/r4bsshkm6w.1
Contributors:
Maria Asdourian,
Nishi Shah,
Ted Jacoby,
Yevgeniy Semenov,
Tracey Otto,
Leah Thompson,
Edward Christopher Dee,
Kerry Reynolds,
Steven Chen

Description

This file discusses additional methodological details and includes a supplemental table summarizing cirAE characteristics in patients who developed multiple cirAEs after ICI therapy.

Files

Categories

Oncology, Dermatological Disease, Adverse Event, Medical Dermatology, Immune Checkpoint Blockade

License